1. Jones DB. Decision-making in the management of microbial keratitis. Ophthalmology. 1981; 88:814–20.
Article
2. Erie JC, Nevitt MP, Hodge DO, Ballard DJ. Incidence of ulcerative keratitis in a defined population from 1950 through 1988. Arch Ophthalmol. 1993; 111:1665–71.
Article
3. Franklin D, Scott M. Staphylococcus epidermidis infection. Ann Intern Med. 1983; 99:834–9.
4. Cokingtin CD, Hyndiuk RA. Bacterial kratitis. Tabbara KF, Hyndiuk RA, editors. Infection of the Eye. 2nd ed.Boston: Little Brown and Company;1996. p. 338–9.
5. Schaefer F, Bruttin O, Zografos L, Guex-Crosier Y. Bacterial keratitis: a prospective clinical and microbiological study. Br J Ophthalmol. 2001; 85:842–7.
Article
6. Toshida H, Kogure N, Inoue N, Murakami A. Trends in microbial keratitis in Japan. Eye Contact Lens. 2007; 33:70–3.
Article
7. Hahn YH, Hahn TW, Tchah H, et al. Epidemiology of infectious keratitis(II): A multicenter study. J Korean Ophthalmol Soc. 2001; 42:247–65.
8. Jang YS, Hahn YH. Epidemiology of staphylococcus epidermidis keratitis. J Korean Ophthalmol Soc. 2002; 43:665–71.
9. Park JH, Lee SB. Analysis on inpatients with infectious keratitis: causative organisms, clinical aspects and risk factors. J Korean Ophthalmol Soc. 2009; 50:1152–66.
Article
10. Davis JL, Koidou-Tsiligianni A, Pflugfelder SC, et al. aberrations staphylococcal endophthalmitis. Increase in antimicrobial resistance. Ophthalmology. 1988; 95:1404–10.
11. Goldstein MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology. 1999; 106:1313–8.
12. Miño De Kaspar H, Hoepfner AS, Engelbert M, et al. Antibiotic resistance pattern and visual outcome in experimentally-induced Staphylococcus epidermidis endophthalmitis in a rabbit model. Ophthalmology. 2001; 108:470–8.
13. Mukerji N, Vajpayee RB, Sharma N. Technique of area measurement of epithelial defects. Cornea. 2003; 22:549–51.
Article
14. Hahn YH, Lee SJ, Hahn TW, et al. Antibiotic susceptibilities of ocular isolates from patients with bacterial keratitis: A multicenter study. J Korean Ophthalmol Soc. 1999; 40:2401–10.
15. Sotozono C, Inagaki K, Fujita A, et al. Methicillin-resistant Staphylococcus aureus and methicillin-resistant Staphylococcus epidermidis infections in the cornea. Cornea. 2002; 21:S94–101.
Article
16. Tabbara KF, El-Sheikh HF, Aabed B. Extended wear contact lens related bacterial keratitis. Br J Ophthalmol. 2000; 84:327–8.
Article
17. Miller DM, Vedula AS, Flynn HW Jr, et al. Endophthalmitis caused by staphylococcus epidermidis: in vitro antibiotic susceptibilities and clinical outcomes. Ophthalmic Surg Lasers Imaging. 2007; 38:446–51.
Article
18. Recchia FM, Busbee BG, Pearlman RB, et al. Changing trends in the microbiologic aspects of postcataract endophthalmitis. Arch Ophthalmol. 2005; 123:341–6.
Article
19. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol. 2002; 133:463–6.
20. Betanzos-Cabrera G, Juárez-Verdayes MA, González-González G, et al. Gatifloxacin, moxifloxacin, and balofloxacin resistance due to mutations in the gyrA and parC genes of Staphylococcus epidermidis strains isolated from patients with endophthalmitis, corneal ulcers and conjunctivitis. Ophthalmic Res. 2009; 42:43–8.
21. Kowal VO, Levey SB, Laibson PR, et al. Use of routine antibiotic sensitivity testing for the management of corneal ulcers. Arch Ophthalmol. 1997; 115:462–5.
Article
22. Kim WJ, Kweon EY, Lee DW, et al. Prognostic factor and antibiotic susceptibility in bacterial keratitis: Results of an eight-year period. J Korean Ophthalmol Soc. 2009; 50:1495–504.
Article